Levetiracetam
Product Images NDC 42254-277

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 42254-277). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (4aad770b A342 45c5 8199 21a124060314 01)

Chemical structure of levetiracetam, showing a pyrrolidinone ring attached to an ethyl side chain and an amide group. The diagram depicts bonds including wedge and dash to indicate stereochemistry around the chiral carbon.*

FDA Label Image

Dcfgv (4aad770b A342 45c5 8199 21a124060314 02)

A bar graph comparing the percentage of patients in three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The y-axis represents the percentage of patients ranging from 0% to 45%. The Placebo group shows 7.4%, Levetiracetam 1000 mg/day shows 37.1%, and Levetiracetam 3000 mg/day shows 39.6%. The x-axis labels also indicate the sample size (N) for each group.*

FDA Label Image

Eerrt (4aad770b A342 45c5 8199 21a124060314 03)

A vertical bar chart comparing the percentage of patients among three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day. The y-axis shows percentage of patients from 0% to 45%. The Placebo group has about 6.3%, Levetiracetam 1000 mg/day about 20.8%, and Levetiracetam 2000 mg/day about 35.2% of patients.*

FDA Label Image

Mkol (4aad770b A342 45c5 8199 21a124060314 04)

A bar chart comparing the percentage fractions of two groups: Placebo (N=104) and Levetiracetam 3000 mg/day (N=180). The Levetiracetam group shows a higher percentage (39.4%) compared to the Placebo group (14.4%). The y-axis represents the percentage fractions from 0% to 45%.*

FDA Label Image

Lahoon (4aad770b A342 45c5 8199 21a124060314 05)

A bar graph comparing the percentage of patients in two groups: Placebo (N=97) and Levetiracetam (N=101). The Levetiracetam group shows a higher percentage of patients (44.6%) compared to the Placebo group (19.6%). The y-axis represents the percentage of patients, ranging from 0% to 45%.*

FDA Label Image

Pgtc55 (4aad770b A342 45c5 8199 21a124060314 06)

A bar chart comparing the percentage of patients in placebo (45.2%) and Levetiracetam (72.2%) groups from clinical data, with a note indicating statistical significance versus placebo.*

FDA Label Image

Levetiracetam 1000mg (4aad770b A342 45c5 8199 21a124060314 07)

The label for Levetiracetam 1000 mg tablets by Rebel Distributors Corp displays the product name, strength, dosage form, and NDC 42254-277-60. It includes dosage details, tablet description, lot and expiration placeholders, and storage instructions. The label shows Physician Partner as distributor with a red alert for keeping medication away from children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.